AGENT FOR THE TREATMENT OF MULTIPLE SCLEROSIS
International application PCT/RU2018/050142 priority 21.11.2017
- Russia No.2017140515 stated 21.11.2017
A method of therapy for multiple sclerosis has been developed—to relieve symptoms, reduce theincidence of relapses and stimulatethe regeneration of the myelin membranes of neurons, i.e.everything that has beneficial effects on the course of the disease in the subject.
Injectionis proposed to the subject needy in this, witha growth hormone in a certain amount with acertain regime, or insulin-like growth factor 1 (IGF-1) or physiological inducer of growth hormone and/orIGF‑1isinjected orgivenorally.
These methods are effective and safe in terms of side effects.